Skip to content
Trial Eligibility
Menu

Preparedness Through Respiratory Virus Epidemiology and Community Engagement

NCT07147517

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The CHARM network will be established through three primary institutions-Beth Israel Deaconess Medical Center (BIDMC), the University of California San Diego (UCSD), and the University of Washington (UW)-along with their subcontracting institutions. At UCSD and partner sites, the CHARM network will be implemented via the PREVENT project.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Respiratory Infection Virus
  • COVID -19
  • RSV
  • FLU

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
Any age
Sex
All
Healthy volunteers
Accepted
Sponsor
University of California, San Diego
Last updated on ClinicalTrials.gov
November 4, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 2

  • UC San Diego · La Jolla, CA
  • San Ysidro Health · San Ysidro, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.